An interventional study of Incrediwear Semiconductor-Embedded Gloves and Placebo Gloves in Hand Osteoarthritis, sponsored by MSK Doctors & Associates Ltd. Not yet recruiting. Open to participants aged 39 Years and older. Per ClinicalTrials.gov, last updated 2026-11-17.
Sponsored by MSK Doctors & Associates Ltd · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
This clinical trial will investigate whether non-compressive therapeutic gloves improve hand function and reduce pain in people with hand osteoarthritis. The gloves contain semiconductor elements embedded in their fabric. Researchers will compare these gloves with visually identical placebo gloves that do not contain semiconductor elements.
The main question is whether the active gloves improve hand function after 12 weeks compared with placebo gloves. Researchers will also assess pain, grip strength, symptoms and changes seen on magnetic resonance imaging (MRI) over nine months.
The study will involve at least 154 participants aged 39 years or older with diagnosed hand osteoarthritis who do not require immediate hand surgery. It will take place at MSK House in Sleaford, United Kingdom.
After providing written informed consent, participants will be assigned by chance to one of two groups. Each participant will have an equal chance of receiving active or placebo gloves. Neither participants nor the clinical team will know which gloves have been assigned.
Participants will:
Participants may also complete a short video-based movement assessment at the first and last study visits.
The main measure of hand function will be the Australian Canadian Osteoarthritis Hand Index (AUSCAN), a questionnaire about hand symptoms and difficulty with everyday activities. Other assessments will measure pain, hand function, grip strength and changes in the hand joints.
The research team will record unwanted effects during the study. Participants who experience discomfort, irritation or a skin reaction will be advised to remove the gloves and contact the study team.
The findings will help determine whether these therapeutic gloves have a role in managing hand osteoarthritis.
2,977 studies on the registry are indexed under Osteoarthritis; 438 are open to participants now.
This study's planned enrollment of 154 is above the median of 80 across 2,241 interventional studies indexed under Osteoarthritis.
Browse Osteoarthritis studies →MSK Doctors & Associates Ltd is the lead sponsor of 3 studies on the registry; 3 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A condition in which the immune system attacks the body’s own tissues, such as rheumatoid arthritis, lupus, psoriasis, type 1 diabetes or inflammatory bowel disease.
Immunotherapy studies often leave out active autoimmune disease, and some name exceptions, such as thyroid disease on replacement hormone. Check the exceptions this study lists.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Autoimmune disease
A condition in which the immune system attacks the body’s own tissues, such as rheumatoid arthritis, lupus, psoriasis, type 1 diabetes or inflammatory bowel disease.
Immunotherapy studies often leave out active autoimmune disease, and some name exceptions, such as thyroid disease on replacement hormone. Check the exceptions this study lists.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants receive active semiconductor-embedded gloves to wear on their affected hand or hands for nine months. Gloves are worn for a minimum of 20 hours per day, including overnight, during the first 12 weeks, followed by at least 12 hours per day, including overnight, until the nine-month assessment.
Device: Incrediwear Semiconductor-Embedded Gloves
Participants receive identical gloves without semiconductor elements to wear on their affected hand or hands for nine months. Gloves are worn for a minimum of 20 hours per day, including overnight, during the first 12 weeks, followed by at least 12 hours per day, including overnight, until the nine-month assessment.
Other: Placebo Gloves
Non-compressive therapeutic gloves with semiconductor elements incorporated into the fabric. The gloves cover the hand and fingers, with open fingertips. The research team selects the appropriate size, fits the gloves and provides instructions for use.
Visually identical non-compressive gloves without semiconductor elements. The gloves cover the hand and fingers, with open fingertips. The research team selects the appropriate size, fits the gloves and provides instructions for use.
Change in Hand Function Assessed Using the Australian Canadian Osteoarthritis Hand Index (AUSCAN)
Time frame: Baseline and 12 weeks
Change in Hand Pain Assessed Using a Visual Analogue Scale
Time frame: Baseline and months 3, 6 and 9.
Change in Functional Index for Hand Osteoarthritis (FIHOA) Score
Time frame: Baseline and months 3, 6 and 9.
Change in Grip Strength
Time frame: Baseline and month 9.
No study locations are listed for this record.
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Dec 2026; primary completion for Mar 2027, 3 months later.
Of 135 industry-sponsored interventional studies with no phase under Osteoarthritis, half reached primary completion within 38 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 81. This study's planned 3 months is below that.
Counting every sponsor, half of 711 studies reached it within 28 months; a quarter within 11 and three quarters within 57.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
MSK Doctors & Associates Ltd